M. Zheng

发表

Critical Role of Notch‐1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis

Xiyu Liu, Meng-yao Sun, Shixiong Mai, 2022 .

Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2020, Journal of thoracic disease.

A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival.

Yi-long Wu, Jin-Ji Yang, Chao Zhang, 2022, Lung cancer.

Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes

Jin-Ji Yang, Chongrui Xu, Xuchao Zhang, 2022, Journal of Cancer Research and Clinical Oncology.

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2017, Lung cancer.

Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2021, Journal of thoracic disease.

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505).

Y. Wu, H-J. Chen, A. Myers, 2018, Annals of Oncology.

Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.

Yi-long Wu, Jin-Ji Yang, Jie Huang, 2021, Clinical lung cancer.

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

P. Wen, L. Deangelis, R. Govindan, 2015, Cancer.

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Yangqiu Li, Jin-Ji Yang, Chongrui Xu, 2023, Nature Network Boston.

22P EMB-01: An EGFR-cMET bispecific antibody, in advanced/metastatic solid tumors phase I results

P. Jänne, N. Gabrail, Y. Wu, 2022, Annals of Oncology.

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

P. Wen, L. Deangelis, R. Govindan, 2015, Cancer.

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2023, EClinicalMedicine.